The design of optimal model based experiments is finding increasing use in various fields including chemical, pharmaceutical, biological engineering, and biomedicine. The traditional Model Based Optimal Experimental Design (MBOED) techniques focus on improving the parameter precision but do not consider the undesired possibility of increasing the correlation among the estimated parameters. In this paper, we propose a multi-objective optimization based experimental design technique, which provides the trade-off curve between information measure and correlation measure in the form of a Pareto-optimal front. This Pareto-optimal front gives the experimenter the freedom to choose appropriate experimental designs for real world system under investigation. The proposed methodology is illustrated using an example involving the identification of physiological models for characterizing Type 1 diabetic patients.
INTRODUCTION
Building a model is a key step towards developing a better understanding of any system of interest. A good process model can be used to estimate certain variables that are difficult to measure on a frequent basis (i.e. as a soft-sensor), form the basis for process optimization or improvement, process design, or simply to unravel the hidden characteristics of the system. Almost all mathematical models, at the time of their formulation, contain unknown parameters whose estimation is necessary before the model can be put to its intended use. Estimation of these unknown parameters requires experimental data -the data which should ensure parameter estimates with high precision. In this context, various model based optimal experiment design techniques have contributed significantly to the area of chemical kinetics (Yang et al., 2006) , crystallization (Chung et al., 2000 , Fujiwara et al., 2005 , heat and mass transfer (Balsa-Canto et al., 2007) , fermentation (Zhang and Edgar 2008) , systems biology (Banga and Balsa-Canto, 2008) , and many more applications can be found in the recent review on MBOED by (Franceschini and Macchietto, 2008a) . The objective of the traditional MBOED techniques has been to suggest experiment(s) whose implementation will provide data that is rich in information for improving parameter precision. However, improving the information content for parameter precision often results in increased correlation among parameters, which can have adverse consequences during their application (Agarwal and Brisk, 1985; Rodriguez-Fernandez et al., 2006) . It is therefore important to develop approaches that do not have undesirable side effects while seeking to improve parameter precision.
MODEL BASED OPTIMAL EXPERIMENTAL DESIGN
As the name suggests, all MBOED techniques require a mathematical representation of the system under investigation. Hence, before we discuss MBOED techniques in detail, it would be appropriate to outline the process of model building. Here, we consider a deterministic, non-linear dynamic model representation, i.e. described by deterministic ordinary differential equations (ODEs), differential-algebraic equations (DAEs), or partial differential algebraic equations (PDAEs). In the case of ODEs, a generic statement for model is given by,
where x is the vector of time-varying n x state variables, θ is the vector of n θ parameters, f corresponds to model equations, u(t) is the time-varying inputs to the system (i.e., control or manipulated variables, w is the time-invariant control variables, y denotes the vector of n y measured variables, and h is the function relating system states to the measured variables. Generally, h is simply a selector function, and specifies which system states are measured.
Model building can be considered as an iterative process. Starting from the objective for which the process model is developed and some a priori system knowledge like preliminary data or hypothesis, a model structure that has unknown parameters is proposed. The modeller may have some a priori knowledge about the magnitude of the unknown parameters but their precise estimation is done based on experimental data. If there is no prior knowledge about the model parameters, then an initial estimate of these can be obtained from the historical data. The parameter estimates can be obtained by minimizing the deviation of model predicted outputs from experimental data (equation 2).
Equation (2) The use of MBOED techniques as answer to the above questions such that experiments that maximize the information content in data are conducted. In other words, an experiment is defined by the initial condition x 0 , sampling instances, and inputs u(t) chosen from the pre-specified bounds for inputs. In the context of precise parameter estimation, the objective of MBOED techniques is to maximize the precision of estimated parameters (i.e., minimize the variance of the estimated parameters). Under the assumptions of linearity in the vicinity of optimal parameters, the parameter variance can be approximated by (Franceschini and Macchietto, 2008a) :
Here, Z is the matrix of local sensitivity coefficients of measured outputs w.r.t all parameters and V is the parameter variance-covariance matrix whose diagonal elements correspond to variance of individual parameters and offdiagonal elements are the covariance between parameter pairs (equation 4). For models linear in parameters, equation 3 is exact, but, for non-linear case, it is an approximation deduced from Cramer-Rao inequality (Franceschini and Macchietto, 2008a) . In cases of highly non-linear model representation, this approximation can result in spurious/uninformative experimental designs; hence, a model should be assessed for severe non-linearity before applying FIM (Fisher information matrix) based MBOED techniques.
( )
Note that
T Z Z in equation (3) is replaced by FIM in equation (4). This is because
T Z Z can be ill-conditioned in many instances and its inverse cannot be calculated: thus it is advisable to work on FIM (Zhang and Edgar, 2008) . In the literature, various MBOED criteria based on a measure of FIM have been mentioned, of which D-, A-, and E-optimal designs have commonly been applied in a wide variety of science and engineering applications.
D-optimal design maximizes the determinant of FIM,
which is equivalent to minimization of the volume of the parameter confidence ellipsoid ( Figure 1 ). 2. A-optimal design maximizes the trace of FIM or minimizes the dimension of surrounding geometry, and 3. E-optimal design maximizes the smallest eigenvalue of FIM or minimizes the length of major axis of the parameter confidence ellipsoid. Interestingly, maximizing the information measure of FIM unavoidably leads to increase in correlation among the estimated parameters. In equation (4), covariance is employed but, being scale dependent, it can be misleading to minimize it. Hence, we desire to work with the parameter correlation matrix which is obtained by dividing the each element of the variance-covariance matrix by the respective parameter variance, as follows, 
Increased correlation can have serious implications on parameter estimation, foremost of which is non-unique identification of parameters, which renders the system unidentifiable (Rodriguez-Fernandez et al., 2006; Banga and Balsa-Canto, 2008) . Additionally, increased correlation among parameters can deteriorate the parameter precision (Agarwal and Brisk, 1985) and may result in spurious point estimates (Franceschini and Macchietto, 2008a) . Adverse effect of correlation among parameters is known for decades and the first study to circumvent this issue was published by (Pritchard and Bacon, 1978) . In their experimental design 8th IFAC Symposium on Advanced Control of Chemical Processes Furama Riverfront, Singapore, July 10-13, 2012
formulation, instead of maximizing a measure of FIM, they minimized a correlation measure (averaged squared sum of correlation elements), as shown in equation (6):
This criterion was successful in minimizing correlation, but at the cost of wider confidence interval or decreased parameter precision. To overcome this drawback, Franceschini and Macchietto (2008b) have recently proposed four anticorrelation (AC) based design criteria. In one of the formulation, they constrained the specific correlation element(s) below a pre-specified limit and maximized the eigenvalue(s) of FIM. In another formulation, they minimized the correlation elements violating a pre-specified threshold and constrained the eigenvalue(s). See Franceschini and Macchietto (2008b) for more details. The possible drawback of these AC design criteria is sub-optimal solution because of constraining the search space. To overcome this problem, we propose multi-objective optimization based OED criterion (equation 7), (Information measure) (Correlation measure)
In the above formulation, the first objective is maximization of determinant of FIM and the second objective is minimization of Euclidean norm of correlation matrix R . Other correlation measure can be chosen as the second objective, but we focussed on minimization of overall correlation. This design criterion is named as DMOO (a multi-objective variant of D-design). Similarly, other design criteria like AMOO or EMOO can be realized.
APPLICATION OF THE PROPOSED MOO BASED OED METHOD
To illustrate the benefits of the proposed method, a simple 3 parameter model describing glucose-insulin kinetics in Type 1 diabetic patients is considered. First proposed in 1981 (Bergman et al., 1981) , the mathematical representation of glucose-insulin homeostasis, was known as minimal model. This model was further modified by various researchers to represent the physiology of Type 1 diabetes patients. One such modification (Lynch and Bequette, 2002 ) is known as modified minimal model is used in this work. The model, also used by (Galvanin et al., 2010) in their backoff based MBOED, is represented by the following set of ODEs: 
where A is the amount of carbohydrates (CHO) in the meal (fixed at 75g in this study), t max = 40min is the time required to reach the maximum glucose concentration in the accessible compartment, f = 0.8 is the dimensionless factor which represents the fraction of CHO being absorbed. This meal model suggests that ingested meal does not alter the glucose concentration immediately; rather there is a lag between food ingestion and subsequent manifestation of glucose concentration in the blood serum. The exogenous insulin infusion, u(t), is represented by,
Here, bolus u represents the kinetics (eqn 11) of subcutaneous bolus insulin (U b ) given at the start of experiment (at t=0). This subcutaneous insulin dose compensates for meal ingestion. In this in silico clinical test, the time of meal intake is decided by clinician, and it can vary between 2 min to 30min after the insulin bolus dose. The bolus u kinetics is adapted from Nucci and Cobelli (2000) , and is given by: 
where U b is bolus amount given at t=0 and decided by clinician, T 50 is time required to reach 50% absorption of the bolus insulin. T 50 is given by,
where a, b, and s depend on insulin type. In this paper, Humalog is considered as insulin type for which a = 5.2min/U, b = 41min, and s = 1.6 (Chen and Tsai, 2009 ). In equation (10), basal u is time varying basal insulin infusion, which is represented by piecewise constant profile. In this clinical test, we have assumed that only 4 piecewise constant moves are allowed for basal insulin infusion.
The objective here is to design optimal basal insulin infusion profile, amount of bolus dose at t=0, time of meal ingestion, and corresponding blood glucose measurement instances which will result in information-rich data for precise estimation of θ 1 , θ 2 , and θ 3 while keeping the correlation between estimated parameters low. The experiment duration is decided based on the last sampling instance.
The problem of designing the clinical test becomes more interesting because of patient specific constraints. The function of insulin is to bring down the glucose concentration within the window of 60-120 mg/dL. However, in diabetes patients, the upper limit is typically relaxed to a value such as 160 mg/dL. Patients are categorized as having experienced a hyperglycemic episode if they exceed this 160 mg/dL limit; in a similar fashion, a hypoglycemic episode is said to occur 8th IFAC Symposium on Advanced Control of Chemical Processes Furama Riverfront, Singapore, July 10-13, 2012 when the patient's blood glucose concentration goes below 60 mg/dL. Hypoglycemia is more dangerous than hyperglycemia because it can result in coma or even death. Thus, to ensure patient safety, hypo and hyperglycemia are considered as hard and soft constraints, respectively when designing the model-based optimal experiment. During optimization, the penalty function method is employed to avoid hypo and hyperglycemic episodes during the implementation of the obtained optimal insulin profile.
Additional system constraints considered in this work are: 1) A total of 10 blood glucose measurements are allowed.
2) Consecutive blood samples must have a minimum of 10 min gap. The last sampling instance decides the clinical test duration. 3) A minimum gap of 10 min is mandated between two consecutive switches of insulin infusion rates.
RESULTS AND DISCUSSION
The clinicians' goal of personalizing the insulin dosage for Type 1 diabetes patients under their care would require the construction of individual patient models. To enable this, the patients will undergo Modified Oral Glucose Tolerance Test (MOGTT) wherein they ingest a stipulated meal (e.g. 75g CHO) after a bolus insulin dose at t=0; thereafter, for the duration of the experiment, basal insulin is administered to the subject to bring his/her glucose level within permissible limits. During this period, 10 blood samples are collected and glucose concentration is measured from the samples. These measurements are used for identifying the parameters in the patient model. Hence, developing the individual patient model with minimum resources and least discomfort to the patient demands proper experimental planning; this effort should culminate in a good patient model (parameters as precise as possible). In this direction, two MBOED criteria: D-optimal design and its proposed counterpart DMOO design are simulated and compared. D-optimal design criterion is chosen for illustration here because it ensures improvement in precision of all parameters, and is widely advocated in MBOED literature. The modified minimal model used shows symmetric response for ±15% insulin step change and thus possesses open-loop linearity for its nominal parameter values (Balakrishnan et al., 2011) . This suggests that the system is suitable for linear FIM based MBOED applications.
The MBOED techniques require an initial guess for parameters: we chose them to be 1.3 times the true values of the parameters. The true parameter values are taken to be θ true = [0.025, 0.015, 1.26×10 -5 ]. For the obtained optimal insulin profile and sampling instances (using the assumed parameter values), glucose concentration data was generated using θ true . To mimic the real patient data, a homoscedastic gaussian noise was added to the obtained blood glucose concentration values with variance = 10 mg 2 /dL 2 . The randomness in noise follows i.i.d. (independent and identically distributed) characteristics.
For the DMOO design, a Pareto-optimal front is obtained (Figure 2) . One extreme point of DMOO Pareto-optimal front is equivalent to D-optimal design (point corresponding to maximum information measure), while the other extreme corresponds to Pritchard and Bacon criterion (point corresponding to minimum correlation measure).
Figure 2:
Pareto-optimal front for DMOO design Between these two extremes, the experimenter has the freedom to choose any appropriate trade-off solution. Here, we have chosen a trade-off solution by eyeballing the obtained Pareto front, with more emphasis on the correlation measure. Hereafter, the selected experiment design will be referred to as the DMOO design. The obtained designs from D-optimal design and DMOO design were implemented on an in silico patient and parameter estimates were obtained (Table 1) . Additional information to compare the results of both design criteria is also given in Table 1 . From the results in Table 1 , it is evident that DMOO design results in better point estimates than its traditional counterpart, D-design, and with decreased correlation among parameters (15.5% decrease in norm of correlation matrix) than that obtained by E-optimal design. Although these improvements come at the cost of a lower t-value, the obtained t-values indicate that all parameters are statistically significant.
One can notice from glucose concentration profiles for Dand DMOO designs in Figure 3 that despite the penalties for hypo-and hyperglycemia, the glucose concentration breaches the constraint of hyperglycemia. The reason for this is parametric mismatch (initial parameter guess and true parameters are different (Chu and Hahn, 2008) , which may lead to potentially unsafe designs. However, this issue can be overcome by employing robust design techniques in Körkel et al., 2004 or recently proposed backoff strategy (Galvanin et al., 2010) . A simpler approach can be conservative design, where instead of constraining the glucose concentration between 60-160 mg/dL, we constrain it between 70-140 mg/dL (for example). This conservative approach can possibly account for parametric mismatch and result in safer and informative designs. We intend to explore this conservative design approach in future and compare its performance with backoff strategy of Galvanin et al. (2010) and other robust experimental design techniques. Similar to hyperglycemic breach, clinicians can anticipate hypoglycemic breach, which is more dangerous, and can possibly be avoided by considering the basal glucose value at 108 mg/dL instead of 81 mg/dL used here. The higher basal glucose value has been suggested and used by (Balakrishnan et al., 2011 , Hovorka et al., 2004 , Hernjak and Doyle III, 2005 . Note that DMOO design results in lower experimental duration (~250 min) when compared to D-design (~300 min).
Also, the insulin required for DMOO and D-design is ~8 units and 11 units, respectively. Thus, reduced experimental time and reduced insulin dose can significantly reduce the experimental cost and inconvenience to patients. We have proposed a MOO based OED criterion and illustrated its application on a 3-parameter Type 1 diabetes patient model. The DMOO design criterion performs better than its traditional counterpart (D-design), not only in terms of better point estimates for the parameters and decreased parameter correlation, but also in terms of reduced insulin requirement and clinical test duration (i.e. reduced cost solution). Although the proposed MOO based design criterion is computationally intensive, it comes with the advantage of freedom to choose an appropriate trade-off between information and correlation measures. The applications and benefits of the proposed MOO based OED criterion can be realized in many fields where traditional design techniques have already been implemented. Further improvements in proposed MOO based MBOED technique will be explored as future works, as discussed in Section 4 of this paper.
